Depression

Showing NaN - NaN of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Depression Trial in United States (Pharmacogenetic testing, Clinical decisions support)

Recruiting
  • Depression
  • Pharmacogenetic testing
  • Clinical decisions support
  • Wilmington, Delaware
  • +13 more
Jul 21, 2023

Depression Trial in Jacksonville (Ketamine Hydrochloride, Placebo)

Not yet recruiting
  • Depression
  • Ketamine Hydrochloride
  • Placebo
  • Jacksonville, Florida
    Mayo Clinic Florida
Mar 26, 2023

Depressive Disorder, Depression, Depression, Postpartum Trial in United States (Ganaxolone, Placebo)

Completed
  • Depressive Disorder
  • +9 more
  • Glendale, California
  • +32 more
Jan 4, 2023

Depression, Acute Pain, Chronic Pain Trial in United States (Pharmacogenetic testing, Clinical decisions support)

Recruiting
  • Depression
  • +2 more
  • Pharmacogenetic testing
  • Clinical decisions support
  • Wilmington, Delaware
  • +12 more
Jan 6, 2023

Bipolar I Disorder, Mania, Depression Trial in Worldwide (Cariprazine, Placebo)

Completed
  • Bipolar I Disorder
  • +2 more
  • Little Rock, Arkansas
  • +111 more
Dec 12, 2022

Depression, MDD Trial in Jacksonville, Rochester (Clinical decision support tool)

Completed
  • Depression
  • Major Depressive Disorder
  • Clinical decision support tool
  • Jacksonville, Florida
  • +1 more
Dec 9, 2022

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +42 more
Sep 22, 2021

Depression Trial in Jacksonville (Tele-psychiatry consult)

Withdrawn
  • Depression
  • Tele-psychiatry consult
  • Jacksonville, Florida
    Mayo Clinic in Florida
Feb 5, 2019

Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)

Completed
  • Bipolar Disorder
  • Depression
  • Little Rock, Arkansas
  • +73 more
Jan 10, 2019

Depression Trial in Worldwide (Armodafinil)

Terminated
  • Depression
  • Birmingham, Alabama
  • +157 more
Aug 23, 2018

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712, Escitalopram, Fluoxetine)

Completed
  • Depressive Disorder
  • +4 more
  • Birmingham, Alabama
  • +143 more
Sep 14, 2018

Depression, Depressive Disorder, Depressive Disorder, Treatment-resistant Trial in United States (LFMS)

Completed
  • Depression
  • +3 more
  • LFMS
  • Garden Grove, California
  • +11 more
Oct 31, 2017

Sexual Dysfunctions, Psychological, Depression Trial in United States (flibanserin 50 mg to 100 mg qhs, flibanserin 100 mg qhs,

Terminated
  • Sexual Dysfunctions, Psychological
  • Depression
  • flibanserin 50 mg to 100 mg qhs
  • +2 more
  • Costa Mesa, California
  • +41 more
Jul 14, 2016

Cognitive/Functional Effects, Delirium, Depression Trial in United States (dietary supplement, drug, other)

Completed
  • Cognitive/Functional Effects
  • +4 more
  • vitamin E
  • +2 more
  • Scottsdale, Arizona
  • +14 more
Jul 12, 2016

Depression Trial in United States (Armodafinil, Placebo)

Completed
  • Depression
  • Birmingham, Alabama
  • +39 more
Apr 26, 2016

Depression Trial in Worldwide (Armodafinil, Placebo)

Completed
  • Depression
  • Birmingham, Alabama
  • +91 more
Apr 26, 2016

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712 + ADT, Placebo + ADT)

Completed
  • Depressive Disorder
  • +4 more
  • OPC-34712 + ADT
  • Placebo + ADT
  • Birmingham, Alabama
  • +70 more
Nov 30, 2015

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712 + ADT, Placebo + ADT)

Completed
  • Depressive Disorder
  • +4 more
  • OPC-34712 + ADT
  • Placebo + ADT
  • Arcadia, California
  • +56 more
Oct 26, 2015

Depression Trial in Worldwide (Duloxetine, Escitalopram, BMS-820836 Placebo)

Completed
  • Depression
  • Birmingham, Alabama
  • +92 more
Sep 23, 2015

Depression Trial in Worldwide (Placebo matching with BMS-820836, BMS-820836)

Terminated
  • Depression
  • Birmingham, Alabama
  • +143 more
Sep 23, 2015

Depression Trial in Worldwide (Duloxetine, Placebo matching with BMS-820836, BMS-820836)

Completed
  • Depression
  • Little Rock, Arkansas
  • +83 more
Sep 23, 2015

MDD, Depression Trial in India, United States (TC-5214, Placebo)

Completed
  • Major Depressive Disorder
  • Depression
  • Tuscaloosa, Alabama
  • +50 more
Mar 14, 2014

MDD, MDD, Depression Trial in Puerto Rico, United States (TC-5214, Placebo)

Completed
  • Major Depressive Disorder
  • +2 more
  • Birmingham, Alabama
  • +93 more
Mar 14, 2014